MedPath

The Safety and Effectiveness of CVA-FLOW Software Device for Acute Ischemic Stroke

Not Applicable
Recruiting
Conditions
Stroke
Stroke, Acute
Stroke, Ischemic
Stroke Hemorrhagic
Stroke, Cardiovascular
Interventions
Diagnostic Test: CVAid Flow
Registration Number
NCT05745051
Lead Sponsor
Cvaid Medical
Brief Summary

The purpose of this study is to demonstrate the effectiveness and safety of CVA-FLOW, a digital health AI based Telestroke system developed by CVAID Ltd. Company aims to assist certified medical staff to triage acute ischemic stroke patients using dedicated algorithms in order to support application for market approval for CVA-FLOW device.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Suspected hyper-acute stroke patient at the ED, prior to treatment (tPA or EVT)
  • Age≥18
Exclusion Criteria
  • Intubated patients upon arrival
  • Time from stroke symptoms onset > 24h
  • Patients post treatment (tPA of EVT)
  • Patient in acute psychosis state
  • Patients who do not speak Hebrew as their mother tongue

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Evaluate the safety and effectiveness of CVA-FLOW Software Device for acute ischemic strokeCVAid FlowThe purpose of this study is to demonstrate the effectiveness and safety of CVA-FLOW, a digital health AI based Telestroke system developed by CVAID Ltd. Company aims to assist certified medical staff to triage acute ischemic stroke patients using dedicated algorithms in order to support application for market approval for CVA-FLOW device.
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of stroke severity classification by CVA-CORE algorithmafter 24 hours

Stroke severity classification will be calculated by the CVA-CORE system algorithm and compared to the imaging results (interpretation).

Secondary Outcome Measures
NameTimeMethod
Device operational performanceafter 24 hours

The investigator shall assess the use of the device during the operation, and conclude a summary evaluation after the end of the usage. Evaluation items are shown below:Item / evaluation

* Usage experience: Simple to operate/difficult to operate

* Errors: No errors occurs during the usage/ Errors occurs during the usage

* Known safety issues during use of CVA-MED and CVA-COLLECTOR

Trial Locations

Locations (1)

Shaare Zedek Medical Center

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath